A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)

NCT04398953 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed / Refractory Mantle Cell Lymphoma (MCL)

Interventions

DRUG: TQ-B3525

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.